Aicar
Product Quick Detail
- albert@kafenbio.com
- +8618011892373
- Packaging
- Discreet and Disguised
- Delivery
- Within 12 Hours After Receiving Your Payment
Specifications
Email:albert@kafenbio.com
Skype:kafenbiotech
WhatsApp:+8618011892373
www.kafenbiotech.com
1.Quick Details:
Acadesine
Alias: AICAR; AICA-RIBOSIDE; AMPK; Z-RIBOSIDE
CAS: 2627-69-2
EINECS: 220-097-5
Molecular Formula: C9H14N4O5
Molecular Weight: 258.23
Assay: 98%
Apperance: White or off-white powder.
Usage: Pharmaceutical intermediates. For the treatment of cardiovascular diseases
2.Product Description:
AICAR (AICA-Riboside) strongly inhibits the transcription of PPAR&alpha and the coactivation of PPAR&alpha. In adipocyte studies it has been shown to antagonize lipolysis induced by isoprenaline and has been suggested for use in kinase cascade research. Additionally, research indicates that AICAR blocks the differentiation of 3T3-L1 (sc-2243) adipocytes. Studies demonstrate that AICAR can mimic the activity of insulin (sc-211647) by activating AMPK (AMP-activated protein kinase), and affecting the expression of PEPCK-M (PEPCK) and glucose-6-phosphatase (G6Pase). The 5-aminoimidazole-4-carboxamide ribonucleoside (ZMP) is the monophosphorylated derivative of AICA-Riboside, and it can serve as the substrate for the aminoimidazole carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase (ATIC). AICAR is an inhibitor of Hsp90, mTOR and p70 S6 Kinase.
- Country: China (Mainland)
- Business Type: Manufacturer
- Market:Americas,Africa,Asia,Emerging Markets,Europe,European Union,G20,Middle East,Oceania,Canada,USA,Brazil,Australia,New Zlealand,UK
- Founded Year:2002
- Address:No.128,Hanxing East Rd,Zhongcun,Panyu District
- Contact:Albert Gordon
